iShares Biotechnology ETF Holdings
IBB was created on 2001-02-05 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 5217.84m in AUM and 255 holdings. IBB tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges.
Last Updated: 5 days, 10 hours ago
Last reported holdings - iShares Biotechnology ETF
| Ticker | Name | Est. Value |
|---|---|---|
|
GILD
|
Gilead Sciences Inc | $440.6 million |
|
AMGN
|
Amgen Inc | $438.4 million |
|
VRTX
|
Vertex Pharmaceuticals Inc | $435.8 million |
|
REGN
|
Regeneron Pharmaceuticals Inc | $328.4 million |
|
ALNY
|
Alnylam Pharmaceuticals Inc | $234.6 million |
|
IQV
|
IQVIA Holdings Inc | $163.5 million |
|
MTD
|
Mettler-Toledo International Inc | $143.0 million |
|
ARGX
|
argenx SE ADR | $137.5 million |
|
NTRA
|
Natera Inc | $132.5 million |
|
WAT
|
Waters Corp | $122.0 million |
|
BIIB
|
Biogen Inc | $111.8 million |
|
INSM
|
Insmed Inc | $106.7 million |
|
BNTX
|
BioNTech SE ADR | $103.4 million |
|
ILMN
|
Illumina Inc | $86.3 million |
|
ONC
|
BeOne Medicines Ltd ADR | $84.3 million |
|
INCY
|
Incyte Corp | $79.0 million |
|
UTHR
|
United Therapeutics Corp | $78.0 million |
|
NBIX
|
Neurocrine Biosciences Inc | $74.8 million |
|
EXEL
|
Exelixis Inc | $67.3 million |
|
BMRN
|
BioMarin Pharmaceutical Inc | $63.1 million |
|
GMAB
|
Genmab AS ADR | $60.4 million |
|
MRNA
|
Moderna Inc | $52.7 million |
|
BPMC
|
Blueprint Medicines Corp | $48.8 million |
|
TECH
|
Bio-Techne Corp | $47.5 million |
|
MEDP
|
Medpace Holdings Inc | $45.9 million |
|
CRL
|
Charles River Laboratories International Inc | $44.6 million |
|
ASND
|
Ascendis Pharma AS ADR | $43.5 million |
|
HALO
|
Halozyme Therapeutics Inc | $39.3 million |
|
RVMD
|
Revolution Medicines Inc Ordinary Shares | $39.1 million |
|
RGEN
|
Repligen Corp | $37.7 million |
|
BBIO
|
BridgeBio Pharma Inc | $36.2 million |
|
IONS
|
Ionis Pharmaceuticals Inc | $34.7 million |
|
TEM
|
Tempus AI Inc Class A common stock | $32.7 million |
|
MDGL
|
Madrigal Pharmaceuticals Inc | $31.9 million |
|
ROIV
|
Roivant Sciences Ltd Ordinary Shares | $30.7 million |
|
ALKS
|
Alkermes PLC | $28.2 million |
|
VRNA
|
Verona Pharma PLC ADR | $28.0 million |
|
LEGN
|
Legend Biotech Corp ADR | $26.9 million |
|
PCVX
|
Vaxcyte Inc Ordinary Shares | $25.3 million |
|
ADMA
|
ADMA Biologics Inc | $25.1 million |
|
AXSM
|
Axsome Therapeutics Inc | $25.0 million |
|
BRKR
|
Bruker Corp | $24.0 million |
|
PTCT
|
PTC Therapeutics Inc | $23.5 million |
|
ACAD
|
ACADIA Pharmaceuticals Inc | $23.0 million |
|
CYTK
|
Cytokinetics Inc | $22.9 million |
|
CRSP
|
CRISPR Therapeutics AG | $22.2 million |
|
AKRO
|
Akero Therapeutics Inc | $22.2 million |
|
RYTM
|
Rhythm Pharmaceuticals Inc | $20.9 million |
|
NUVL
|
Nuvalent Inc Class A | $20.3 million |
|
SWTX
|
SpringWorks Therapeutics Inc Ordinary Shares | $19.9 million |
|
RNA
|
Avidity Biosciences Inc Ordinary Shares | $19.7 million |
|
KRYS
|
Krystal Biotech Inc | $19.7 million |
|
RARE
|
Ultragenyx Pharmaceutical Inc | $19.6 million |
|
MRUS
|
Merus NV | $19.5 million |
|
PTGX
|
Protagonist Therapeutics Inc | $18.9 million |
|
ZLAB
|
Zai Lab Ltd ADR Repr 1 Shs | $16.9 million |
|
SRRK
|
Scholar Rock Holding Corp | $16.1 million |
|
CRNX
|
Crinetics Pharmaceuticals Inc | $16.0 million |
|
ACLX
|
Arcellx Inc | $15.6 million |
|
KYMR
|
Kymera Therapeutics Inc Ordinary Shares | $15.2 million |
|
XENE
|
Xenon Pharmaceuticals Inc | $14.3 million |
|
SMMT
|
Summit Therapeutics Inc Ordinary Shares | $14.0 million |
|
VCEL
|
Vericel Corp | $12.5 million |
|
VCYT
|
Veracyte Inc | $12.4 million |
|
TWST
|
Twist Bioscience Corp | $12.3 million |
|
MIRM
|
Mirum Pharmaceuticals Inc | $12.0 million |
|
BCRX
|
BioCryst Pharmaceuticals Inc | $11.9 million |
|
AGIO
|
Agios Pharmaceuticals Inc | $11.9 million |
|
SRPT
|
Sarepta Therapeutics Inc | $11.3 million |
|
APLS
|
Apellis Pharmaceuticals Inc | $11.1 million |
|
DNLI
|
Denali Therapeutics Inc | $10.7 million |
|
IDYA
|
IDEAYA Biosciences Inc | $10.7 million |
|
FOLD
|
Amicus Therapeutics Inc | $10.3 million |
|
NVCR
|
NovoCure Ltd | $10.1 million |
|
GRFS
|
Grifols SA ADR | $10.0 million |
|
ARWR
|
Arrowhead Pharmaceuticals Inc | $9.9 million |
|
RXRX
|
Recursion Pharmaceuticals Inc Class A | $9.2 million |
|
BEAM
|
Beam Therapeutics Inc | $9.1 million |
|
ADPT
|
Adaptive Biotechnologies Corp | $9.1 million |
|
APGE
|
Apogee Therapeutics Inc | $9.0 million |
|
ARQT
|
Arcutis Biotherapeutics Inc Ordinary Shares | $8.7 million |
|
ETNB
|
89bio Inc Ordinary Shares | $8.4 million |
|
TARS
|
Tarsus Pharmaceuticals Inc Ordinary Shares | $8.2 million |
|
GRAL
|
GRAIL Inc | $8.2 million |
|
XTSLA
|
BlackRock Cash Funds Treasury SL Agency | $7.9 million |
|
BHVN
|
Biohaven Ltd | $7.7 million |
|
TVTX
|
Travere Therapeutics Inc Ordinary Shares | $7.6 million |
|
DVAX
|
Dynavax Technologies Corp | $7.4 million |
|
CGON
|
CG Oncology Inc | $7.3 million |
|
STVN
|
Stevanato Group SpA | $7.1 million |
|
MNKD
|
MannKind Corp | $6.8 million |
|
TXG
|
10x Genomics Inc Ordinary Shares - Class A | $6.7 million |
|
IMVT
|
Immunovant Inc | $6.7 million |
|
JANX
|
Janux Therapeutics Inc Ordinary Shares | $6.6 million |
|
EWTX
|
Edgewise Therapeutics Inc | $6.5 million |
|
None
|
E-MINI HEALTH CARE SECTOR SEP 25 | $6.5 million |
|
IRON
|
Disc Medicine Inc Ordinary Shares | $6.4 million |
|
MESO
|
Mesoblast Ltd ADR | $6.3 million |
|
NAMS
|
NewAmsterdam Pharma Co NV | $6.2 million |
|
VERA
|
Vera Therapeutics Inc Class A | $6.2 million |
|
ALVO
|
Alvotech | $6.0 million |
|
AUPH
|
Aurinia Pharmaceuticals Inc | $5.9 million |
|
IMCR
|
Immunocore Holdings PLC ADR | $5.9 million |
|
CDNA
|
CareDx Inc | $5.8 million |
|
GLPG
|
Galapagos NV ADR | $5.7 million |
|
NTLA
|
Intellia Therapeutics Inc | $5.7 million |
|
EVO
|
Evotec SE ADR | $5.7 million |
|
GERN
|
Geron Corp | $5.6 million |
|
NVAX
|
Novavax Inc | $5.6 million |
|
DYN
|
Dyne Therapeutics Inc Ordinary Shares | $5.5 million |
|
CRMD
|
Cormedix Inc | $5.4 million |
|
NRIX
|
Nurix Therapeutics Inc Ordinary Shares | $5.2 million |
|
WVE
|
WAVE Life Sciences Ltd | $5.1 million |
|
ZYME
|
Zymeworks Inc Registered Shs | $5.1 million |
|
GPCR
|
Structure Therapeutics Inc ADR | $5.0 million |
|
SPRY
|
ARS Pharmaceuticals Inc | $4.9 million |
|
SNDX
|
Syndax Pharmaceuticals Inc | $4.9 million |
|
ABCL
|
AbCellera Biologics Inc Ordinary Shares | $4.7 million |
|
SYRE
|
Spyre Therapeutics Inc | $4.7 million |
|
None
|
RUSSELL 2000 EMINI CME SEP 25 | $4.6 million |
|
AVXL
|
Anavex Life Sciences Corp | $4.5 million |
|
PRAX
|
Praxis Precision Medicines Inc Ordinary Shares | $4.5 million |
|
VERV
|
Verve Therapeutics Inc | $4.4 million |
|
QURE
|
uniQure NV | $4.4 million |
|
CNTA
|
Centessa Pharmaceuticals PLC ADR | $4.3 million |
|
COGT
|
Cogent Biosciences Inc | $4.2 million |
|
ELVN
|
Enliven Therapeutics Inc | $4.1 million |
|
LENZ
|
LENZ Therapeutics Inc | $4.1 million |
|
ANAB
|
AnaptysBio Inc | $4.0 million |
|
REPL
|
Replimune Group Inc | $3.6 million |
|
XNCR
|
Xencor Inc | $3.4 million |
|
IOVA
|
Iovance Biotherapeutics Inc | $3.3 million |
|
URGN
|
UroGen Pharma Ltd | $3.2 million |
|
CSTL
|
Castle Biosciences Inc | $3.2 million |
|
CVAC
|
CureVac NV Ordinary Shares | $3.2 million |
|
ALT
|
Altimmune Inc | $3.2 million |
|
ABUS
|
Arbutus Biopharma Corp | $3.1 million |
|
MLYS
|
Mineralys Therapeutics Inc | $3.1 million |
|
RCUS
|
Arcus Biosciences Inc | $3.0 million |
|
SAGE
|
Sage Therapeutics Inc | $3.0 million |
|
FTRE
|
Fortrea Holdings Inc | $3.0 million |
|
TBPH
|
Theravance Biopharma Inc | $2.9 million |
|
AVBP
|
ArriVent BioPharma Inc | $2.9 million |
|
ZVRA
|
Zevra Therapeutics Inc | $2.9 million |
|
STOK
|
Stoke Therapeutics Inc | $2.9 million |
|
DAWN
|
Day One Biopharmaceuticals Inc | $2.9 million |
|
KALV
|
KalVista Pharmaceuticals Inc | $2.9 million |
|
VIR
|
Vir Biotechnology Inc | $2.8 million |
|
KROS
|
Keros Therapeutics Inc | $2.7 million |
|
ARVN
|
Arvinas Inc | $2.7 million |
|
MYGN
|
Myriad Genetics Inc | $2.7 million |
|
KURA
|
Kura Oncology Inc | $2.7 million |
|
RLAY
|
Relay Therapeutics Inc Ordinary Shares | $2.6 million |
|
None
|
USD CASH | $2.6 million |
|
PHAT
|
Phathom Pharmaceuticals Inc Ordinary shares | $2.5 million |
|
NUVB
|
Nuvation Bio Inc Ordinary Shares - Class A | $2.5 million |
|
TSHA
|
Taysha Gene Therapies Inc Ordinary Shares | $2.4 million |
|
OPK
|
OPKO Health Inc | $2.4 million |
|
LAB
|
Standard BioTools Inc | $2.4 million |
|
FLGT
|
Fulgent Genetics Inc | $2.4 million |
|
ORIC
|
ORIC Pharmaceuticals Inc | $2.4 million |
|
RGNX
|
Regenxbio Inc | $2.4 million |
|
CTKB
|
Cytek Biosciences Inc | $2.2 million |
|
AUTL
|
Autolus Therapeutics PLC ADR | $2.1 million |
|
ORKA
|
Oruka Therapeutics Inc | $2.1 million |
|
MGTX
|
MeiraGTx Holdings PLC | $2.1 million |
|
EBS
|
Emergent BioSolutions Inc | $2.1 million |
|
SANA
|
Sana Biotechnology Inc Ordinary Shares | $2.1 million |
|
RIGL
|
Rigel Pharmaceuticals Inc | $2.0 million |
|
TRVI
|
Trevi Therapeutics Inc | $2.0 million |
|
PACB
|
Pacific Biosciences of California Inc | $1.9 million |
|
AMLX
|
Amylyx Pharmaceuticals Inc | $1.9 million |
|
DNA
|
Ginkgo Bioworks Holdings Inc | $1.9 million |
|
ITOS
|
ITeos Therapeutics Inc Ordinary Shares | $1.9 million |
|
SLDB
|
Solid Biosciences Inc | $1.9 million |
|
TYRA
|
Tyra Biosciences Inc | $1.9 million |
|
CMPS
|
Compass Pathways PLC ADR | $1.8 million |
|
ARCT
|
Arcturus Therapeutics Holdings Inc | $1.8 million |
|
HUMA
|
Humacyte Inc | $1.8 million |
|
CGEM
|
Cullinan Therapeutics Inc | $1.8 million |
|
ABSI
|
Absci Corp | $1.8 million |
|
PSNL
|
Personalis Inc | $1.7 million |
|
RCKT
|
Rocket Pharmaceuticals Inc | $1.7 million |
|
TNGX
|
Tango Therapeutics Inc | $1.7 million |
|
AURA
|
Aura Biosciences Inc | $1.7 million |
|
ATXS
|
Astria Therapeutics Inc | $1.6 million |
|
TRML
|
Tourmaline Bio Inc | $1.6 million |
|
VNDA
|
Vanda Pharmaceuticals Inc | $1.5 million |
|
TERN
|
Terns Pharmaceuticals Inc Ordinary Shares | $1.5 million |
|
IBRX
|
ImmunityBio Inc Ordinary Shares | $1.5 million |
|
PRTA
|
Prothena Corp PLC | $1.5 million |
|
PGEN
|
Precigen Inc | $1.5 million |
|
MRVI
|
Maravai LifeSciences Holdings Inc Ordinary Shares - Class A | $1.4 million |
|
AVIR
|
Atea Pharmaceuticals Inc Ordinary Shares | $1.4 million |
|
ERAS
|
Erasca Inc | $1.4 million |
|
ADCT
|
ADC Therapeutics SA | $1.4 million |
|
OLMA
|
Olema Pharmaceuticals inc Ordinary Shares | $1.3 million |
|
BCYC
|
Bicycle Therapeutics PLC ADR | $1.3 million |
|
NGNE
|
Neurogene Inc | $1.3 million |
|
ANNX
|
Annexon Inc Ordinary Shares | $1.3 million |
|
QTRX
|
Quanterix Corp | $1.3 million |
|
TECX
|
Tectonic Therapeutic Inc | $1.3 million |
|
GLUE
|
Monte Rosa Therapeutics Inc | $1.2 million |
|
MXCT
|
MaxCyte Inc | $1.2 million |
|
EDIT
|
Editas Medicine Inc | $1.2 million |
|
RAPP
|
Rapport Therapeutics Inc | $1.2 million |
|
CDXS
|
Codexis Inc | $1.1 million |
|
SVRA
|
Savara Inc | $1.1 million |
|
CRVS
|
Corvus Pharmaceuticals Inc | $1.1 million |
|
ALMS
|
Alumis Inc | $1.1 million |
|
ALLO
|
Allogene Therapeutics Inc | $1.0 million |
|
CATX
|
Perspective Therapeutics Inc | $1.0 million |
|
IMMP
|
Immutep Ltd ADR | $977524 |
|
INZY
|
Inozyme Pharma Inc Ordinary Shares | $971228 |
|
FDMT
|
4D Molecular Therapeutics Inc Ordinary Shares | $968336 |
|
YMAB
|
Y-mAbs Therapeutics Inc | $965596 |
|
SLN
|
Silence Therapeutics PLC ADR | $948893 |
|
TRDA
|
Entrada Therapeutics Inc | $934329 |
|
CYBN.NE
|
Cybin Inc Ordinary Shares | $925114 |
|
INBX
|
Inhibrx Biosciences Inc | $904873 |
|
ENTA
|
Enanta Pharmaceuticals Inc | $861570 |
|
None
|
CASH COLLATERAL USD SGAFT | $812000 |
|
VYGR
|
Voyager Therapeutics Inc | $811245 |
|
FHTX
|
Foghorn Therapeutics Inc Ordinary Shares | $803220 |
|
CRGX
|
Cargo Therapeutics Inc | $780760 |
|
FATE
|
Fate Therapeutics Inc | $749934 |
|
ACIU
|
AC Immune SA | $720948 |
|
DSGN
|
Design Therapeutics Inc | $711281 |
|
THRD
|
Third Harmonic Bio Inc | $696338 |
|
ALEC
|
Alector Inc | $685250 |
|
IRWD
|
Ironwood Pharmaceuticals Inc Class A | $648801 |
|
LXEO
|
Lexeo Therapeutics Inc | $644098 |
|
LRMR
|
Larimar Therapeutics Inc | $644015 |
|
PRME
|
Prime Medicine Inc | $584935 |
|
RNAC
|
Cartesian Therapeutics Inc | $517000 |
|
CCCC
|
C4 Therapeutics Inc Ordinary Shares | $495092 |
|
NKTX
|
Nkarta Inc Ordinary Shares | $491001 |
|
MGNX
|
Macrogenics Inc | $488056 |
|
PLRX
|
Pliant Therapeutics Inc Ordinary Shares | $444348 |
|
CLYM
|
Climb Bio Inc | $406179 |
|
BMEA
|
Biomea Fusion Inc | $398890 |
|
TKNO
|
Alpha Teknova Inc | $383457 |
|
KYTX
|
Kyverna Therapeutics Inc | $382898 |
|
TCRX
|
TScan Therapeutics Inc | $355447 |
|
LYEL
|
Lyell Immunopharma Inc Ordinary Shares | $353742 |
|
STRO
|
Sutro Biopharma Inc | $339260 |
|
PYXS
|
Pyxis Oncology Inc | $328017 |
|
NMRA
|
Neumora Therapeutics Inc | $273491 |
|
PEPG
|
PepGen Inc | $266363 |
|
APLT
|
Applied Therapeutics Inc | $218291 |
|
TVGN
|
Tevogen Bio Holdings Inc | $215100 |
|
MRSN
|
Mersana Therapeutics Inc | $172167 |
|
ACRV
|
Acrivon Therapeutics Inc | $165061 |
|
OKUR
|
OnKure Therapeutics Inc Class A Shares | $131229 |
|
ARTV
|
Artiva Biotherapeutics Inc | $117079 |
|
IGMS
|
IGM Biosciences Inc Ordinary Shares | $114799 |
|
None
|
Chinook Therapeutics Inc | $51354 |
|
QTTB
|
Q32 Bio Inc | $40794 |
|
None
|
FUTURES USD MARGIN BALANCE | $7000 |
|
None
|
Cartesian Therapeutics ([Wts/Rts]) 0% | $1799 |
|
None
|
Fusion Pharmaceuticals Inc Cvr | $1034 |
|
None
|
Akouos Cvrs Prvt | $2 |
|
None
|
OMNIAB INC $12.50 VESTING Prvt | $0 |
|
None
|
OMNIAB INC $15.00 VESTING Prvt | $0 |
|
None
|
Cash Offset | $-11.1 million |
Recent Changes - iShares Biotechnology ETF
| Date | Ticker | Name | Change (Shares) |
|---|---|---|---|
| 2025-06-18 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-06-18 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-06-17 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-06-17 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-06-16 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-06-16 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-06-13 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-06-13 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-06-12 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-06-12 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-06-11 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-06-11 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-06-10 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-06-10 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-06-02 |
LYEL
|
Lyell Immunopharma Inc Ordinary Shares | -734,993 |
| 2025-06-02 |
LYEL
|
Lyell Immunopharma Inc Ordinary Shares | 36,749 |
| 2025-05-30 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-05-30 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-05-29 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-05-29 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-05-28 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-05-28 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-05-27 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-05-27 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-05-21 |
SLRN
|
ACELYRIN INC | -449,982 |
| 2025-05-20 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-05-20 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-05-16 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-05-16 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-05-15 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-05-15 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-05-13 |
TSVT
|
2SEVENTY BIO INC | -288,191 |
| 2025-05-09 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-05-09 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-05-08 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-05-08 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-05-07 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-05-07 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-05-06 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-05-06 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-05-05 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-05-05 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-05-02 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-05-02 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-05-01 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-05-01 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-04-29 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-04-29 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-04-28 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-04-28 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-04-25 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-04-25 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-04-24 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-04-24 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-04-23 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-04-23 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-04-22 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-04-22 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-04-21 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-04-21 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-04-16 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-04-16 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-04-15 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-04-15 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-04-14 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-04-14 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-04-11 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-04-11 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-04-10 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-04-10 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-04-09 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-04-09 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-04-08 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-04-08 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-04-07 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-04-07 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-04-04 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-04-04 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-04-03 |
ITCI
|
INTRA CELLULAR THERAPIES INC | -632,015 |
| 2025-04-02 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-04-02 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-04-01 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-04-01 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-03-31 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-03-31 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-03-28 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-03-28 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-03-26 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-03-26 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-03-25 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-03-25 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-03-24 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-03-24 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-03-21 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-03-21 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-03-20 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-03-20 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-03-19 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-03-19 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-03-18 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-03-18 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-03-17 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-03-17 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-03-14 |
ADRO
|
CHINOOK THERAPEUTICS INC | -320,962 |
| 2025-03-14 |
-
|
FUSION PHARMACEUTICALS INC CVR | -1,880 |
| 2025-03-13 |
ADRO
|
CHINOOK THERAPEUTICS INC | 320,962 |
| 2025-03-13 |
-
|
FUSION PHARMACEUTICALS INC CVR | 1,880 |
| 2025-03-12 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-03-12 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-03-11 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-03-11 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-03-10 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-03-10 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-03-07 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-03-07 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-03-06 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-03-06 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-03-05 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-03-05 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-27 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-27 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-02-26 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-02-26 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-25 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-02-25 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-21 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-02-21 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-20 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-02-20 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-19 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-02-19 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-18 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-02-18 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-13 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-02-13 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-12 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-02-12 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-11 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-02-11 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-10 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-10 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-02-07 |
USD
|
USD CASH | None |
| 2025-02-07 |
SGAFT
|
CASH COLLATERAL USD SGAFT | None |
| 2025-02-07 |
USD
|
USD CASH | 0 |
| 2025-02-07 |
SGAFT
|
CASH COLLATERAL USD SGAFT | 0 |
| 2025-02-06 |
RVNC
|
REVANCE THERAPEUTICS INC | None |
| 2025-02-05 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-02-05 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-04 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-02-04 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-03 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-02-03 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-31 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-31 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-30 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-30 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-29 |
OKUR
|
ONKURE THERAPEUTICS INC CLASS A | None |
| 2025-01-29 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-29 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-28 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-28 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-27 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-27 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-24 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-24 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-23 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-23 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-22 |
OKUR
|
ONKURE THERAPEUTICS INC CLASS A | None |
| 2025-01-22 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-22 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-21 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-21 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-16 |
NBTX
|
NANOBIOTIX ADR REPRESENTING SA | None |
| 2025-01-15 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-15 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-14 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-14 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-13 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-13 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-10 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-10 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-09 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-09 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-09 |
ORKA
|
Oruka Therapeutics Inc | -191,766 |
| 2025-01-09 |
ABIO
|
ORUKA THERAPEUTICS INC | None |
| 2025-01-09 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -61,675 |
| 2025-01-09 |
OKUR
|
ONKURE THERAPEUTICS INC CLASS A | None |
| 2025-01-08 |
ORKA
|
Oruka Therapeutics Inc | -191,766 |
| 2025-01-08 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -61,675 |
| 2025-01-08 |
ABIO
|
ORUKA THERAPEUTICS INC | None |
| 2025-01-08 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-08 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-08 |
OKUR
|
ONKURE THERAPEUTICS INC CLASS A | None |
| 2025-01-07 |
PSTX
|
POSEIDA THERAPEUTICS INC | None |
| 2025-01-06 |
RPHM
|
ONKURE THERAPEUTICS INC CLASS A | None |
| 2025-01-06 |
ADRO
|
CHINOOK THERAPEUTICS INC | None |
| 2025-01-06 |
-
|
FUSION PHARMACEUTICALS INC CVR | None |
| 2025-01-06 |
ORKA
|
Oruka Therapeutics Inc | -195,585 |
| 2025-01-06 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -62,910 |
| 2025-01-06 |
ABIO
|
ORUKA THERAPEUTICS INC | None |